bioMérieux S.A. (BMXXY) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-27 15:27:51 ET
bioMérieux S.A. (BMXXY) Q4 2025 Earnings Call February 27, 2026 8:30 AM EST
Company Participants
Aymeric Fichet
Pierre Boulud - Chief Executive Officer
Guillaume Bouhours - Executive VP of Purchasing and Information Systems & CFO
...
Read the full article on Seeking Alpha
For further details see:
bioMérieux S.A. (BMXXY) Q4 2025 Earnings Call Transcript
Biomerieux ADR
NASDAQ: BMXXY
BMXXY Trading
12.13% G/L:
$12.11 Last:
10,804 Volume:
$10.80 Open:
BMXXY Latest News
August 26, 2025 02:00:00 pm
OhioHealth Partners with bioMérieux as Newest Global Antimicrobial Stewardship Center of Excellence
August 05, 2025 02:44:00 pm
bioMérieux Develops Game Changing Quality Control Solution GENE-UP® PRO HRM
March 18, 2025 12:26:00 pm
bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance
February 25, 2025 06:00:00 am
bioMérieux Receives Health Canada Approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel
